Acquiring Company
Cencora
Acquired Company
OneOncology
ConshohockenNashvilleBiotechnologyHealth CarePharmaceuticalDescription
Cencora has successfully acquired OneOncology, leading to a 61-basis-point margin expansion in its U.S. Healthcare Solutions business. The acquisition strengthens Cencora's profitability despite pressures from lower-margin pharmaceutical sales. Increased financing costs were noted due to the acquisition, but overall metrics for profit and EPS showed positive gains.
Don't miss Cencora's next move
Get an email the moment Cencora makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired OneOncology?
OneOncology was acquired by Cencora, based in Conshohocken. The deal was reported on August 16, 2026. Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora is publicly traded (COR) and operates in Biotechnology.
When did Cencora acquire OneOncology?
Cencora's acquisition of OneOncology was reported on August 16, 2026. Cencora has successfully acquired OneOncology, leading to a 61-basis-point margin expansion in its U.S. Healthcare Solutions business. The acquisition strengthens Cencora's profitability despite pressures from lower-margin pharmaceutical sales. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does OneOncology do?
It is privately held, and is based in Nashville.